We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA TURNS TO RISK-BENEFIT TEST FOR SUPPLEMENT MAKERS
FDA TURNS TO RISK-BENEFIT TEST FOR SUPPLEMENT MAKERS
May 19, 2004
Just one week after its final rule banning dietary supplements containing ephedra took effect, the FDA settled the cross hairs of its regulatory sights firmly on the rest of the supplement industry, saying it will employ a risk-benefit test it has never used with supplements to more closely monitor the products and vigorously pursue enforcement actions against those it considers unsafe.